Thinking of joining a study?

Register your interest

NCT04285242 | Recruiting | Cancer


Metabolic and Immunological Phenotyping in Patients With Cancer
Sponsor:

CCTU- Cancer Theme

Information provided by (Responsible Party):

CCTU- Cancer Theme

Brief Summary:

An observational study to investigate cachexia in participants with non-haematological cancer.

Condition or disease

Cancer

Non-Hematologic Malignancy

Intervention/treatment

Observational assessments

Detailed Description:

A single-centre, non-randomised, observational study. This study will investigate the systemic metabolic and immunological changes that occur in cachexia. The aim is to better understand the mechanism(s) underlying weight loss in people with non-haematological cancer. This will help to facilitate future research to generate treatments to reverse weight loss and improve outcomes.

Study Type : Observational
Estimated Enrollment : 40 participants
Official Title: Metabolic and Immunological Phenotyping in Patients With Cancer
Actual Study Start Date : December 7, 2021
Estimated Primary Completion Date : August 10, 2023
Estimated Study Completion Date : September 19, 2023

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Accepts Healthy Volunteers
Criteria
Inclusion Criteria
  • Have given written informed consent to participate
  • Be aged 18 years or over at the time of signing the informed consent form
  • Have a histological or cytological diagnosis of a non-haematological cancer
  • Are willing and able to comply with study procedures and visits
Exclusion Criteria
  • Active infection, as determined by the investigator based on clinical symptoms and / or fever and / or requirement for antibiotics
  • Current treatment with chemotherapy, oral steroids or other immunosuppressive drugs (within 7 days of baseline investigations or during the study phase)
  • Significant acute, chronic or psychiatric condition or laboratory abnormality which in the judgment of the investigator would place the patient at undue risk or interfere with the study.
  • Intolerance to dairy products
  • Women, who are pregnant, plan to become pregnant or are lactating

Metabolic and Immunological Phenotyping in Patients With Cancer

Location Details


Please Choose a site



Metabolic and Immunological Phenotyping in Patients With Cancer

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Recruiting

United Kingdom, Cambridgeshire

Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust,

Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ

Recruiting

United Kingdom, England

Cambridge University Hospitals NHS Foundation Trust

Cambridge, England, United Kingdom, CB2 2QQ

Loading...